Business | Thomson Reuters | Tuesday September 22, 2015
Serum Institute of India Ltd, Asia's largest vaccine maker, has halted plans to sell a minority stake in the company, as global market volatility has dented the appetite of private equity and sovereign wealth funds for big-ticket investments, its CEO said.
www.ndtv.com/business